Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.
about
Prostate cancer stem cells: the role of androgen and estrogen receptorsEvaluation of a novel approach to circulating tumor cell isolation for cancer gene panel analysis in patients with breast cancer.Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigmsThe role of mRNA splicing in prostate cancer.SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression.Multiple gene aberrations and breast cancer: lessons from super-responders.Consequence of the tumor-associated conversion to cyclin D1bCholine Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target.Cyclin D2 is a GATA4 cofactor in cardiogenesis.Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.Alternative splicing programs in prostate cancer.AR function in promoting metastatic prostate cancerRB Loss Promotes Prostate Cancer Metastasis.The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness.Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression.Therapeutic Challenge With a CDK 4/6 Inhibitor Induces an RB-dependent SMAC Mediated Apoptotic Response in Non-Small Cell Lung Cancer.HIC1 loss promotes prostate cancer metastasis by triggering epithelial-mesenchymal transition.Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
P2860
Q26778415-E9CD63C0-2D2C-4AC2-B52E-D198504DFF7EQ33684887-16427171-E6BE-4708-8764-EF8538320647Q33756991-FF5E6C25-62FD-4D09-BE6C-0156F2804007Q33922376-16E012D4-9CED-47E3-9D23-8EDA98E5942CQ35562215-DB95CE19-0733-49D8-8980-61F161A653E6Q35645466-35437FBC-66F7-4F93-A99C-B8FC75C7C859Q35822584-D969A74C-7621-4445-9646-6ED3BE150076Q36849142-BE8AE96D-C676-4757-A5B6-9EE6AF80AB72Q37544077-E856B734-D653-426B-B71F-F05F4431827DQ37709535-89307133-4BBF-4006-8ECE-6F193FF5F377Q38132132-5903A42B-97F6-4E5A-A6D7-556D9A42185FQ38178555-744DD8FC-DC52-4E19-9B76-76A262158340Q38727367-270C2483-0D4C-469D-A3A8-C0FBB93B9D98Q38962238-C7ADFF87-7D42-4E06-9EDF-58A661E2F045Q44930465-2CF1EE78-7599-4ADF-9243-79B0A40106DEQ47223157-1D479865-6256-44A4-AFCF-1883671C3D5BQ48201362-29BB86ED-79B1-4A20-8575-53E87F338664Q52564290-387FE28D-CA81-476B-AE1F-88C8B79B6665
P2860
Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.
@ast
Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.
@en
type
label
Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.
@ast
Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.
@en
prefLabel
Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.
@ast
Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.
@en
P2093
P2860
P50
P356
P1476
Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.
@en
P2093
Adam Ertel
Alessandro Fatatis
Christopher McNair
Danielle L Jernigan
Donald P McDonnell
Felix Y Feng
Jeffry L Dean
Kari Wilder-Romans
Mark Shilkrut
Michael A Augello
P2860
P304
P356
10.1172/JCI64750
P407
P577
2012-12-21T00:00:00Z